Maintaining catheter patency and minimizing occlusions can be important steps in your efforts to enhance patient safety, improve patient outcomes, and reduce costs.
But despite your efforts, central line occlusions, which are frequently caused by blood reflux,1 remain a significant issue that can result in delays in critical patient care, increased risk of infection, and increased healthcare costs. That's why reducing the risk of catheter occlusions may help you decrease the need for expensive declotting agents such as t-PA, and reduce the clinical costs associated with managing catheter occlusions.
Neutron's breakthrough anti-reflux technology helps you stop occlusions before they start, while providing a safe and effective microbial barrier.
Unlike other technologies, such as positive displacement needlefree connectors, Neutron is the only device FDA-cleared to prevent multiple forms of reflux into a catheter and utilize ICU Medical’s patented needlefree connector technology which has been proven to minimize contamination and help you lower the risk of catheter related bloodstream infections (CRBSI)2,3,4